Abstracts Archive - Page 400 of 1683 - ATC Abstracts

2020 American Transplant Congress
Making History, Saving Lives: One OPOs Experience Making History by Being the First in the Nation to Successfully Allocate Seven Organs for Transplant from a Donation after Circulatory Death (DCD) Donor
J. B. Nave, A. J. Boyer, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donors Services, Oklahoma City, OK
*Purpose: At the time of this recovery, our OPO’s percentage of DCD donors was 41%. Continuing to maximize the gift successfully by increasing the percentage…
2020 American Transplant Congress
Evaluating Postoperative Opioid Requirements of Kidney Transplant Recipients
M. A. Muir¹, K. R. Szempruch², R. E. Dupuis¹, A. H. Toledo³, P. Serrano Rodriguez³
¹Pharmacotherapy and Experimental Therapeutics, UNC Eshleman School of Pharmacy, Chapel Hill, NC, ²Pharmacy, UNC Medical Center, Chapel Hill, NC, ³Surgery - Transplant, UNC Medical Center, Chapel Hill, NC
*Purpose: Multimodal analgesia with non-opioid analgesics in the setting of enhanced recovery after surgery (ERAS) pathway has proven beneficial in managing pain and decreasing adverse…
2020 American Transplant Congress
Can Organ Donor Potential Be Determined from Death Certificates? A Case Report
S. Gunderson, J. Kemink, C. Topp, W. Payne, T. Brown, B. Welsch
LifeSource, Minneapolis, MN
*Purpose: The 12/17/19 CMS proposed rule revises outcome measures for OPOs using CDC Multiple Cause of Death to determine donation potential defined as the number…
2020 American Transplant Congress
First U.S. DCD Heart Procured/Transplanted after Normothermic Regional Perfusion
A. L. Friedman¹, Z. N. Kon², D. E. Smith², B. Sullivan³, J. Carillo², N. Moazami²
¹LiveOnNY, New York, NY, ²Cardiothoracic Surgery, NYU Langone Transplant Institute, New York, NY, ³NYU Langone Transplant Institute, New York, NY
*Purpose: We successfully planned, procured and transplanted a heart after a Donation After Cardiac Death (DCD) protocol with post-declaration implementation of in vivo cardiopulmonary bypass…
2020 American Transplant Congress
Perfusion Regulated Organ Therapeutics with Enhanced Controlled Testing (PROTECT): Novel Human Model to Mitigate Ischemia-Reperfusion Injury in Liver Transplant
M. Nazzal, E. Madsen, M. Nguyen, A. Welu, H. Madnawat, C. Manithody, C. Denton, D. Blackall, D. Carpenter, J. Teckman, C. Varma, A. Jain
Saint Louis University, Saint Louis, MO
*Purpose: Despite a global organ shortage, there is almost a 10% discard rate of ‘marginal donor livers’ (MDL), deemed unsuitable for transplantation due to the…
2020 American Transplant Congress
Delayed Kidney Graft Function in Simultaneous Pancreas-Kidney Transplant Recipients is Associated with Pancreas Allograft Failure
S. Parajuli, B. Muth, B. C. Astor, R. R. Redfield, D. Mandelbrot, J. Odorico, A. Djamali, D. Kaufman
University of Wisconsin, Madison, WI
*Purpose: Delayed graft function (DGF) is a common complication associated with significant untoward effects in kidney-alone transplantation. The incidence and outcomes following kidney delayed graft…
2020 American Transplant Congress
Intraoperative Oxygen Delivery and Acute Kidney Injury after Liver Transplantation
W. Kim, H. Lee, H. Yoon, K. Suh
Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Although intraoperative hemodynamic variables were reported to be associated with acute kidney injury (AKI) after liver transplantation, the time-dependent association between intraoperative oxygen delivery…
2020 American Transplant Congress
Comparison of Basiliximab for Induction Therapy in Kidney Transplant Recipients on Post-Operative Days 0 and 4 versus Post-Operative Days 0 and 3
C. Schardt, R. Yau, A. Burgos, C. Tunwar
Pharmacy, CHI St. Luke's Health Baylor St. Luke's Medical Center, Houston, TX
*Purpose: Current dosing recommendations for the administration of basiliximab on post-operative days (POD) 0 and 4 stem from two phase 3 renal transplant studies. Limited…
2020 American Transplant Congress
Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation
R. Shahbazov¹, A. Popovic¹, D. Friedman², I. Bandler², S. Loerzel¹, K. Heslin², R. Hod Duvarai³, B. Gallay⁴, O. Pankewycz⁴, M. Laftavi¹
¹Surgery, Upstate Medical University, Syracuse, NY, ²College of Medicine, Upstate Medical University, Syracuse, NY, ³Pathology, Upstate Medical University, Syracuse, NY, ⁴Medicine, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Our purpose was to investigate the difference in outcomes between…
2020 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
H. Tedesco Jr., C. T. Felipe, L. Viana, M. Cristelli, N. Tenório, V. Lima, V. Azevedo, K. Ficher, J. Rezende, R. Demarchi, M. Nakamura, Y. Dreige, G. Ormenesse, J. Taddedo, L. Takara, C. Santos, L. Damasceno, J. Pestana
Nephrology Division, Hospital Do Rim, Sao Paulo, Brazil
*Purpose: The aim of this study is to compare the efficacy and safety of SRL versus EVR versus MPA in kidney transplant recipients*Methods: This is…